Christopher P. Smith, M.D., M.B.A., Principal Investigator, site specific research project
Assistant Professor
Specialist in Neurourology and Voiding Disorders
Medical School: Northwestern
University Medical School, Chicago, Illinois
Residency: Baylor College of
Medicine, Houston, Texas
Fellowship: Neurourology and
Female Urology, University of Pittsburgh School
of Medicine
Clinical Interests: Neurourology,
incontinence and voiding dysfunction
Research Interests: Spinal cord
injury and the use of botulinum toxin to treat
various lower urinary tract disorders
Significant Professional Activities:
- American Foundation of Urological Disease Scholar 2000-2002
Selected Publications:
Khera, M., Somogyi, G. T., Salas, N. A., Kiss, S., Boone, T. B., Smith, C.: In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology, 66: 208-212, 2005.
Smith, C. P., Chancellor, M. B.: How to treat refractory OAB using injectable botulinum toxin. Urology Times, May 1, 2005.
Smith, C. P., Vemulakonda, V. M., Kiss, S., Boone, T. B., Somogyi, G. T.: Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: Effect of botulinum toxin A. Neurochem Int, 47: 291-297, 2005.
Vemulakonda, V. M., Somogyi, G. T., Kiss, S., Salas, N. A., Boone, T. B., Smith, C. P.: Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation. J Urol, 173: 621-624, 2005.
Khera, M., Boone, T. B., Smith, C. P.: Botulinum Toxin Type A: A Novel approach to treatment of recurrent urethral strictures. J Urol, 172: 574-575, 2004.
Khera, M., Somogyi, G. T., Kiss, S., Boone, T. B., Smith, C. P.: Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int, 45: 987-993, 2004.
Lai, H. H., Boone, T. B., Yang, G., Smith, C. P., Kiss, S., Thompson, T. C., Somogyi, G. T.: Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder. Neurochem Int, 45: 1185-1193, 2004.
Smith, C. P., Radziszewski, P., Borkowski, A., Somogyi, G. T., Boone, T. B., Chancellor, M.: Botulinum toxin -A has antinociceptive effects in treating interstitial cystitis. Urology, 64: 871-875, 2004.
Smith, C. P., Somogyi, G. T., Boone, T. B.: Botulinum toxin in urology: evaluation using an evidence-based medicine approach. Natl Clin Practice, 1: 31-37, 2004.
Smith, C. P., Somogyi, G. T., Chancellor, M. B., Appell, R.: A case for botulinum toxin-A in idopathic bladder overactivity. Curr Urol Rep, 5: 432-436, 2004.
Lai, H. H., Smith, C. P., Teh, B. S., Butler, B. E., Boone, T. B.: Pelvic radiotherapy does not increase the complications rates of artificial urinary sphincter implantation. Int J Radiat Oncol Biol Phys, 57: S273, 2003.
Smith, C. P., Boone, T. B., DeGroat, W. C., Chancellor, M., Somogyi, G. T.: Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions. Brain Res Bull, 61: 165-171, 2003.
Smith, C. P., Chancellor, M. B.: Best of the 2002 AUA Annual Meeting. Reviews in Urology, 4: 122-123, 2002.
Smith, C. P., Somogyi, G. T., Chancellor, M. B.: Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Current Urology Reports, 3: 382-387, 2002.
Smith, C. P., Somogyi, G. T., Chancellor, M.
B.: Botulinum toxin treatment of urethral and
bladder dysfunction. International Braz J Urol,
28: 545-552, 2002.
Contact Information
The Scott Department of Urology
6560 Fannin, Suite 2100
Houston, Texas 77030
Phone: 713-798-4001
Fax: 713-798-5553
cps@bcm.edu
